Raymond James Financial Inc Enzo Biochem Inc Transaction History
Raymond James Financial Inc
- $264 Billion
- Q4 2024
A detailed history of Raymond James Financial Inc transactions in Enzo Biochem Inc stock. As of the latest transaction made, Raymond James Financial Inc holds 17,016 shares of ENZ stock, worth $9,869. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,016Holding current value
$9,869% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ENZ
# of Institutions
46Shares Held
15.4MCall Options Held
2.3KPut Options Held
0-
Harbert Fund Advisors, Inc. Birmingham, AL5.18MShares$3 Million3.43% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.53MShares$1.47 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.88MShares$1.09 Million0.0% of portfolio
-
Potomac Capital Management, Inc.1.48MShares$859,4103.63% of portfolio
-
Viex Capital Advisors, LLC Sunny Isles Beach, FL1.33MShares$773,9979.62% of portfolio
About ENZO BIOCHEM INC
- Ticker ENZ
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 48,720,500
- Market Cap $28.3M
- Description
- Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates through three segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. Th...